Efficacy and Safety of Excimer Light versus Excimer Light and 50% Trichloroacetic Acid in Treatment of Vitiligo

Efficacy and Safety of Excimer Light versus Excimer Light and 50% Trichloroacetic Acid in Treatment of Vitiligo: A Comparative Study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202501881143221

Enrollment

Registered

2025-01-08

Start date

2025-01-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

Excimer laser alone group

Excimer Light and Trichloroacetic Acid group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of any age and both sexes, presented with Stable vitiligo

Exclusion criteria

Exclusion criteria: patients with active vitiligo lesions patients who have received local, systemic, or phototherapy with vitiligo in the last 6 months patients with a history of TCA hypersensitivity patients with a history of scars or keloids patients with an active skin infection at the treatment site

Design outcomes

Primary

Measure	Time frame
repigmentation of the skin	—

Secondary

Measure	Time frame
side effect of the treatment	—

Countries

Egypt

Contacts

Public ContactMofreh Ismail

Lecturer of Dermatology

Mofrehmansour@gmail.com00201006698741

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026